HOME >> MEDICINE >> NEWS
New drug development facility helps move medicines to market

TetraQ, a preclinical contract research and development (R&D) facility providing services to the global pharmaceutical and biotechnology industries, was officially launched today by Minister for State Development, Employment and Industrial Relations, John Mickel.

The facility, which helps to move medicines out of the laboratory and into the market more quickly, provides expertise and support through preclinical trials of new drugs, which are required before human trials and subsequent release to the market.

Business Development Manager, Rose-marie Pennisi said TetraQ, which received $8.1 million from the Smart State Research Facility Fund in 2005, had now established its position in the market.

She said TetraQ had proven there was a demand for its services, with 150 R&D contracts now completed for 43 clients.

TetraQ has assisted Melbourne-based Metabolic Pharmaceuticals Limited with the preclinical development of a new pain killer made from venom of the Australian marine cone snail and Brisbane company Progen Industries Limited with a new cancer treatment that is now being tested in human trials in hospitals around the world.

"Australian biotech companies, universities, research institutes and the pharmaceutical industry now have access to a highly skilled commercial R&D service with a wealth of experience in the four core disciplines that are required in preclinical drug development," Ms Pennisi said.

The growth of TetraQ shows that the sector is keen to take advantage of the tailored solutions that we offer and keep their R&D dollars in Australia to contribute to the growth of the drug development industry on-shore.

"TetraQ now provides its services internationally and the global market will be a target for future growth. We are also collaborating with drug development companies in other countries to offer our clients access to services not available in Australia and vice versa."


'"/>

Contact: Marlene McKendry
61-440-199-6847
Research Australia
3-Jun-2007


Page: 1 2

Related medicine news :

1. Baby DVDs, videos may hinder, not help, infants language development
2. Millennium development goals: Are we on track?
3. Mid Sweden University leads development of digital color x-rays
4. NIH study tracks brain development in some 500 children across US
5. A first glimpse at healthy brain and behavioral development
6. Role of TRPM8 in the development of prostate cancer
7. SLEEP 2007 to present more than 1,100 new findings and developments on sleep disorders
8. Hebrew University research shows developmental problems for siblings of autistic children
9. New forecasting tool could reduce drug development costs
10. Pittsburgh ear study finds that fluid in the ear does not impair development in children
11. Over 200 million children under age 5 failing to reach their potential in cognitive development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
(Date:9/19/2017)... ... 2017 , ... MelaKids, a Laredo-based company, has introduced a new concept for ... Nature gives us a full supply of melanin – in the back of the ... glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown pigment in ...
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the ... industry itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. ... natural alkaline water technologies, water filtration systems, and consumer education. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone ... the first in the U.S. to incorporate magnesium, a critical property for bone ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)...  Medical professionals are expected to continuously ... their patients. Medical simulations offer clinicians the ... Simulation provides a safe method for teaching ... refine techniques and build confidence, without putting ... such as augmented reality, will now provide ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
Cached News: